CSS
ATYR

Cubist Systematic Strategies’s aTyr Pharma ATYR Stock Holding History

Cubist Systematic Strategies’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,485
Closed -$25.7K – 3592
2024
Q2 		$25.7K Buy
16,485
+4,749
+40% +$8.26K ﹤0.01% 2757
2024
Q1 		$22.9K Sell
11,736
-5,850
-33% -$10.2K ﹤0.01% 3464
2023
Q4 		$24.8K Buy
17,586
+5,625
+47% +$7.21K ﹤0.01% 3334
2023
Q3 		$18.9K Buy
+11,961
New +$22.1K ﹤0.01% 3103
2022
Q1 		– Sell
-16,900
Closed -$126K – 3810
2021
Q4 		$126K Sell
16,900
-34,427
-67% -$287K ﹤0.01% 3147
2021
Q3 		$466K Buy
+51,327
New +$307K 0.01% 2080

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cubist Systematic Strategies's ATYR Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of aTyr Pharma (ATYR) in Q3 2024, closing a stake of 16,485 shares — an estimated $25.7K sold.

Cubist Systematic Strategies first reported a position in ATYR in Q3 2021 and held it in 6 quarters. The position peaked at $466K in Q3 2021. 56 funds tracked by Wall St. Rank hold ATYR as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining aTyr Pharma position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 16,485 aTyr Pharma shares in Q3 2024, an estimated $25.7K.
  • Cubist Systematic Strategies first reported a position in aTyr Pharma in Q3 2021 and held it in 6 quarters.
  • Cubist Systematic Strategies's aTyr Pharma position peaked at $466K in Q3 2021.
  • 56 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.